Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 3897 - 3904 of 11616 results
COVID-19: Handling a Positive Diagnosis in the Workforce
April 8, 2020| Blog| Viewpoint
A Review of the Affordable Care Act at 10 Years, Part 2: Medicaid Expansion
April 8, 2020| Blog| Viewpoint
UPDATED: Leave Tracking and Recordkeeping Under Covid-19: Adjusting for the New Normal
April 8, 2020| Blog| Viewpoint
FDA Expands Face Mask Enforcement Policy to Allow Imports of KN95 Respirators
April 7, 2020| Blog| Viewpoint
DOJ Files False Claims Act Lawsuit Against Anthem for “One-Sided” Chart Review Practices
April 7, 2020| Blog| Viewpoint
Bay Area Office Landlords Get Further Clarity from Updated Shelter in Place Order
April 7, 2020| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.